Carbapenem-resistant enterobacteriaceae containing New Delhi metallo-beta-lactamase in two patients - Rhode Island, March 2012

Morbidity and Mortality Weekly Report

Volumn 61, Issue 24, 2012, Pages 446-448

  Hardy, Erica E ^a   Mermel, Leonard A ^a   Chapin, Kimberle C ^b   Vanner, Cindy ^c   Gupta, Ekta ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BROWN UNIVERSITY   (United States)

^c RHODE ISLAND DEPARTMENT OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE; BETA LACTAMASE NDM 1; BETA-LACTAMASE NDM-1; CARBAPENEM DERIVATIVE;

ARTICLE; CAMBODIA; CASE REPORT; CROSS INFECTION; ENZYMOLOGY; FEMALE; GENETICS; HUMAN; INFECTION CONTROL; ISOLATION AND PURIFICATION; KLEBSIELLA INFECTION; KLEBSIELLA PNEUMONIAE; MULTIDRUG RESISTANCE; TRAVEL; UNITED STATES;

BETA-LACTAMASES; CAMBODIA; CARBAPENEMS; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE; FEMALE; HUMANS; INFECTION CONTROL; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; RHODE ISLAND; TRAVEL;

EID: 84865045150     PISSN: 01492195     EISSN: 1545861X     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Yong D, Toleman MA, Giske CG, et al. Characterization of a new metallo-beta-lactamase gene, blaNDM-1, and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother 2009;53:5046-54.
2. Nordmann P, Poirel L, Walsh TR, Livermore DM. The emerging NDM carbapenemases. Trends Microbiol 2011;19:588-95.
3. Ben-David D, Maor Y, Keller N, et al. Potential role of active surveillance in the control of a hospital-wide outbreak of carbapenem-resistant Klebsiella pneumoniae infection. Infect Control Hosp Epidemiol 2010;31:620-6.
4. Schwaber MJ, Lev B, Israeli A, et al; Israel Carbapenem-Resistant Enterobacteriaceae Working Group. Containment of a country-wide outbreak of carbapenem-resistant Klebsiella pneumoniae in Israeli hospitals via a nationally implemented intervention. Clin Infect Dis 2011;52:848-55.
5. CDC. Laboratory protocol for detection of carbapenem-resistant or carbapenemase-producing, Klebsiella spp. and E. coli from rectal swabs. Atlanta, GA: US Department of Health and Human Services, CDC; 2009. Available at http://www.cdc.gov/hai/pdfs/labsettings/klebsiella_or_ecoli.pdf. Accessed June 18, 2012.
6. CDC. Guidance for control of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae in acute care facilities. MMWR 2009;58:256-60.
7. Wilson ME, Chen LH. NDM-1 and the role of travel in its dissemination. Curr Infect Dis Rep 2012;14:213-26.
8. Kumarasamy KK, Toleman MA, Walsh TR, et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 2010; 10:597-602.
9. Struelens MJ, Monnet DL, Magiorakos AP, Santos O'Connor F, Giesecke J; European NDM-1 survey participants. New Delhi metallo-beta-lactamase 1-producing Enterobacteriaceae: emergence and response in Europe. Euro Surveill 2010;15:pii=19716.
10. Kim MN, Yong D, An D, et al. Nosocomial clustering of NDM-1-producing Klebsiella pneumoniae sequence type 340 strains in four patients at a South Korean tertiary care hospital. J Clin Microbiol 2012;50:1433-6.